医学
安慰剂
可视模拟标度
耐受性
随机对照试验
人口
人造眼泪
外科
内科学
不利影响
环境卫生
病理
替代医学
作者
Edward J. Holland,Jodi Luchs,Paul Karpecki,Kelly K. Nichols,Mitchell Jackson,Kenneth Sall,Joseph Tauber,Monica Roy,Aparna Raychaudhuri,Amir Shojaei
出处
期刊：Ophthalmology
[Elsevier BV]
日期：2016-10-27
卷期号：124 (1): 53-60
被引量：196
标识
DOI：10.1016/j.ophtha.2016.09.025
摘要
Lifitegrast significantly improved symptoms of eye dryness, as measured by EDS, versus placebo in participants with DED. Improvement in EDS was observed as early as day 14. Lifitegrast appeared well tolerated.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
OK
GingerF
斯文的白玉
Criminology34
无极微光
heekkll
adcffgg
My_magnum_opus
dghq
平淡金毛
DW
clinched
皖公网安备34019202002308
